Thursday, September 08, 2011
-
Mad Money Lightning Round: Cramer Likes Ligand Pharmaceuticals (ACW, CNBC, COST, LGND, PSMT, S, T, Jim Cramer, Pre-Market Outlook, Media, Trading Ideas / Thu, 03:58am)
LGND 12.69 -0.02 / Ligand Pharmaceuticals, Inc. Media
From Benzinga's Newsdesk
- 01:20 PM Tech Data Announces $100 Million Share Repurchase Program
- 01:17 PM Ford Reports Sale of Sandusky Plant
- 1:07 PM Apple to Acquire Redmatica -Fanpage
- 1:04 PM Founder of Stocktwits, Howard Lindzon, Says He Just Bought 5,000 Shares of Facebook
- 1:02 PM FDA Issues Warning Letter on Vertex Incivek
- 1:02 PM South Africa's Marcus Says Building Forex Reserves is Challenge, Ready to Move in Any Direction on Rates, World in Worst Position Now Than Before the Crisis, Scale of Global Crisis is Huge
- 01:01 PM The Edelman Financial Group Announces End of "Go Shop" Period
- 12:54 PM Booz Allen Hamilton up 14% on Strong Earnings and Guidance
- 12:51 PM Tillerson Says No Regrets on Purchase of XTO Before Gas Prices Collapsed -Bloomberg
- 12:46 PM Salesforce's Benioff Talks Facebook, Oracle on CNBC Fast Money
- 12:35 PM Ebay Falls 5% on Negative Analyst Comments
- 12:35 PM Post Properties Increases Dividend from $0.22 to $0.25
- 12:27 PM Sandisk Sees 2H Nand Flash Industry Recovery
- 12:27 PM Juncker: Euro-zone Governments Discussing 4-5 Eurobond Variations
- 12:24 PM Perrigo Announces FDA Final Approval Of Tris Pharma's Dextromethorphan Polistirex Extended-Release Oral Suspension
Brain Trust
- Tech Data Announces $100 Million Share Repurchase Program
- Ford Reports Sale of Sandusky Plant
- 5 Global Mendoza Line ETFs (DWX, EEB, FNI)
- The Edelman Financial Group Announces End of "Go Shop" Period
- Booz Allen Hamilton up 14% on Strong Earnings and Guidance
- Salesforce's Benioff Talks Facebook, Oracle on CNBC Fast Money
- Should Research in Motion Sell BlackBerry and Call it Quits?
- Peter Cohen: Euro Zone Could Shrink Back to Original Members
- Post Properties Increases Dividend from $0.22 to $0.25
- Perrigo Announces FDA Final Approval Of Tris Pharma's Dextromethorphan Polistirex Extended-Release Oral Suspension
- Is Facebook Secretly Cloning the iPhone 5?
- Was IBM Smart to Ban Siri?
- 5 Small-Cap Short Ideas
- Earnings Scheduled For May 29
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Social Media Chatter on Dell Around Its Earnings Report
- Opera Would Be "Another Stupid Acquisition" for Facebook, Says Analyst
- Benzinga's Top Pre-Market Gainers
